a Risk Assessment and Management Program Using Telecare Consultation Among Patients With Diabetes Mellitus
NCT ID: NCT05183685
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
780 participants
INTERVENTIONAL
2022-12-10
2025-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Pre-medical Consultation Diabetes Self-care Education Programme on Glycemic Control in Type 2 Diabetes
NCT04092569
Impact of Telehealth Education in Diabetes Patients
NCT05696015
COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes
NCT04723550
Diabetes Telemedicine Consultation: A Systems Improvement Intervention
NCT00119041
Teleconsultation in Type 1 Diabetes Mellitus
NCT02812498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
The participants will receive alternative telecare consultation and face to face consultation every 14 weeks.
telecare consultation
Participants will use zoom to communicate with the doctors in clinic.
Control group
The participants will receive usual face to face consultation every 14 weeks.
Usual face to face consultation
Participants will have face-to-face communication with the doctors in clinic.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
telecare consultation
Participants will use zoom to communicate with the doctors in clinic.
Usual face to face consultation
Participants will have face-to-face communication with the doctors in clinic.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tuen Mun Hospital
OTHER_GOV
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arkers, Wong
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuen Mun Hospital
Tuenmen, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0034230
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.